Differences in incidence and co‐occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33-Reference-Cited by-同舟云学术

Differences in incidence and co‐occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

Published:2010-11-28 Issue:5 Volume:128 Page:1114-1119
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Merikukka Marko¹,Kaasila Marjo¹,Namujju Proscovia B.¹,Palmroth Johanna²,Kirnbauer Reinhard³,Paavonen Jorma⁴,Surcel Heljä‐Marja¹,Lehtinen Matti¹⁵

Affiliation:

1. National Institute for Health and Welfare, Oulu, Finland

2. Department of Obstetrics and Gynecology, Kuopio University Hospital, Kuopio, Finland

3. Department of Dermatology, Medical University, Vienna, Austria

4. Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland

5. School of Public Health, University of Tampere, Tampere, Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.25675

Reference28 articles.

1. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2. Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses

3. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland

4. Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s

5. Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile‐aged Finnish women

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines;Vaccines;2022-10-20

2. Elevated risk of HPV-associated oropharyngeal cancers in husbands of women with anogenital cancer appears calendar-time dependent;2022-10-05

3. Contact patterns and HPV-genotype interactions yield heterogeneous HPV-vaccine impacts depending on sexual behaviors: An individual-based model;Epidemics;2022-06

4. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women;Tumour Virus Research;2022-06

5. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials;The Lancet Infectious Diseases;2021-10